Isthmus Partners LLC Has $15.49 Million Stake in Procter & Gamble Company (The) $PG

Key Points

• Isthmus Partners LLC increased its Procter & Gamble stake by 8.9% in the first quarter, bringing its holdings to 107,277 shares valued at about $15.5 million.
• Procter & Gamble reported better-than-expected earnings of $1.59 per share on revenue of $21.23 billion, and it raised its full-year guidance to 6.83-7.09 EPS.
• The company also boosted its quarterly dividend to $1.0885 per share, implying an annualized dividend of $4.35 and a yield of about 2.9%.

Isthmus Partners LLC boosted its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 8.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 107,277 shares of the company's stock after buying an additional 8,778 shares during the period. Procter & Gamble makes up about 1.6% of Isthmus Partners LLC's investment portfolio, making the stock its 14th biggest position. Isthmus Partners LLC's holdings in Procter & Gamble were worth $15,495,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of PG. E Fund Management Hong Kong Co. Ltd. raised its position in shares of Procter & Gamble by 1,000.0% during the 4th quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company's stock valued at $25,000 after acquiring an additional 150 shares during the last quarter. Park Square Financial Group LLC grew its stake in shares of Procter & Gamble by 65.1% during the fourth quarter. Park Square Financial Group LLC now owns 180 shares of the company's stock worth $26,000 after purchasing an additional 71 shares during the period. Evolution Wealth Management Inc. grew its stake in shares of Procter & Gamble by 1,315.4% during the fourth quarter. Evolution Wealth Management Inc. now owns 184 shares of the company's stock worth $26,000 after purchasing an additional 171 shares during the period. Litman Gregory Wealth Management LLC bought a new stake in Procter & Gamble in the fourth quarter valued at about $26,000. Finally, Maseco LLP bought a new stake in Procter & Gamble in the fourth quarter valued at about $28,000. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Stock Performance

Shares of PG stock opened at $148.58 on Thursday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.53 and a current ratio of 0.73. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $167.25. The company's 50 day moving average price is $146.61 and its two-hundred day moving average price is $148.36. The company has a market capitalization of $345.97 billion, a P/E ratio of 21.72, a price-to-earnings-growth ratio of 6.50 and a beta of 0.39.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.56 by $0.03. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The company had revenue of $21.23 billion during the quarter, compared to the consensus estimate of $21.52 billion. During the same quarter in the prior year, the firm earned $1.54 earnings per share. The firm's revenue was up 7.4% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, analysts expect that Procter & Gamble Company will post 6.9 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Friday, April 24th were issued a dividend of $1.0885 per share. This is a boost from Procter & Gamble's previous quarterly dividend of $1.06. The ex-dividend date was Friday, April 24th. This represents a $4.35 dividend on an annualized basis and a yield of 2.9%. Procter & Gamble's dividend payout ratio is currently 63.60%.

Wall Street Analysts Forecast Growth

PG has been the topic of a number of recent analyst reports. Weiss Ratings restated a "hold (c)" rating on shares of Procter & Gamble in a report on Wednesday, June 24th. Royal Bank Of Canada reduced their price objective on shares of Procter & Gamble from $172.00 to $167.00 and set an "outperform" rating on the stock in a research note on Thursday, April 9th. The Goldman Sachs Group lowered their target price on shares of Procter & Gamble from $159.00 to $155.00 and set a "neutral" rating for the company in a research note on Wednesday, April 8th. Raymond James Financial reduced their price target on shares of Procter & Gamble from $175.00 to $170.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 14th. Finally, Evercore set a $162.00 price objective on shares of Procter & Gamble in a research report on Monday, April 27th. Twelve equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Procter & Gamble presently has an average rating of "Moderate Buy" and an average target price of $161.47.

Procter & Gamble Company Profile

Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.